Literature DB >> 20127252

Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer.

Hua Hu1, Yang Zhang, Mei Zou, Shuai Yang, Xiao-Qiu Liang.   

Abstract

PURPOSE: Telomere dysfunction is believed to be a significant factor in carcinogenesis. To elucidate the carcinogenesis mechanism in gastric cancer, the expression of telomeric proteins and changes in telomere length were investigated during multistage carcinogenesis of gastric cancer.
METHODS: Tissue samples were obtained during surgical operations from the normal gastric mucosa of 10 patients, the precancerous lesions of 15 patients, the gastric cancer tissues (GC) of 20 patients, and of tumors due to gastric cancer with lymph node metastasis (GCLM) from 5 patients. The expression of TRF1, TRF2, and TIN2 proteins was measured by Western blotting, while the expression of TERT, KU70, and BRCA1 proteins was detected using the immunohistochemical method. The mean telomere length was determined by Southern blotting.
RESULTS: Compared with normal gastric mucosa tissues, the expression of TRF1, TRF2, and TIN2 proteins was significantly higher in precancerous lesions, GC, and GCLM (P < 0.01). The expression of TRF1, TRF2, and TIN2 proteins was significantly higher in GC and GCLM than in precancerous lesions (P < 0.01). The expression of TERT and Ku70 proteins in precancerous lesions and GC tissues was significantly higher than that in normal gastric mucosa tissues (P < 0.01). The expression of TERT and Ku70 proteins in GC tissues was significantly higher than in precancerous lesions (P < 0.01). In normal gastric mucosa, the BRCA1 protein was primarily located in the cell nucleus. In precancerous lesions and GC, the expression of the BRCA1 protein was apparent in the cell cytoplasm. The mean telomere length in precancerous lesions, GC, and GCLM was significantly shorter than that in normal gastric mucosa tissues (P < 0.05). The mean telomere length in GC and GCLM was significantly shorter than that in precancerous lesions (P < 0.05). The mean telomere length in all tissue samples was inversely correlated with the level of TRF1, TRF2, TIN2, TERT, and Ku70 proteins.
CONCLUSIONS: Our results suggest that the over-expression of telomeric proteins, TRF1, TRF2, TIN2, TERT, and Ku70, and the transposition of the BRCA1 protein may work together to reduce the telomere length in precancerous lesions and gastric cancer, and could contribute to the multistage carcinogenesis of gastric cancer. These findings offer new insight into the mechanism of carcinogenesis in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127252     DOI: 10.1007/s00432-010-0795-x

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  37 in total

1.  TIN2, a new regulator of telomere length in human cells.

Authors:  S H Kim; P Kaminker; J Campisi
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

Review 2.  The structure and function of telomerase reverse transcriptase.

Authors:  Chantal Autexier; Neal F Lue
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

3.  Control of telomere length by the human telomeric protein TRF1.

Authors:  B van Steensel; T de Lange
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

Review 4.  TRF1, a mammalian telomeric protein.

Authors:  S Smith; T de Lange
Journal:  Trends Genet       Date:  1997-01       Impact factor: 11.639

Review 5.  Telomeres and human disease: ageing, cancer and beyond.

Authors:  Maria A Blasco
Journal:  Nat Rev Genet       Date:  2005-08       Impact factor: 53.242

6.  Interaction of human Ku70 with TRF2.

Authors:  K Song; D Jung; Y Jung; S G Lee; I Lee
Journal:  FEBS Lett       Date:  2000-09-08       Impact factor: 4.124

7.  Expression of telomeric repeat binding factor 1 in non-small cell lung cancer.

Authors:  Jian Hu; Li Sun; Chong Zhang; Xielai Zhou
Journal:  J Surg Oncol       Date:  2006-01-01       Impact factor: 3.454

8.  Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.

Authors:  Cristina Garcia-Aranda; Carmen de Juan; Antonio Diaz-Lopez; Andres Sanchez-Pernaute; Antonio-Jose Torres; Eduardo Diaz-Rubio; Jose-Luis Balibrea; Manuel Benito; Pilar Iniesta
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

9.  High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium.

Authors:  R S Cornelis; S L Neuhausen; O Johansson; A Arason; D Kelsell; B A Ponder; P Tonin; U Hamann; A Lindblom; P Lalle
Journal:  Genes Chromosomes Cancer       Date:  1995-07       Impact factor: 5.006

10.  Telomere length changes in colorectal cancers and polyps.

Authors:  Hyeong Rok Kim; Young Jin Kim; Hyun Jong Kim; Shin Kon Kim; Ji Hee Lee
Journal:  J Korean Med Sci       Date:  2002-06       Impact factor: 2.153

View more
  33 in total

1.  Altered mRNA expression of telomere-associated genes in monoclonal gammopathy of undetermined significance and multiple myeloma.

Authors:  Julieta Panero; Jorge Arbelbide; Dorotea Beatriz Fantl; Hernán García Rivello; Dana Kohan; Irma Slavutsky
Journal:  Mol Med       Date:  2010-07-14       Impact factor: 6.354

Review 2.  The Ku complex: recent advances and emerging roles outside of non-homologous end-joining.

Authors:  Sanna Abbasi; Gursimran Parmar; Rachel D Kelly; Nileeka Balasuriya; Caroline Schild-Poulter
Journal:  Cell Mol Life Sci       Date:  2021-04-15       Impact factor: 9.261

Review 3.  At the Crossroads Between Neurodegeneration and Cancer: A Review of Overlapping Biology and Its Implications.

Authors:  Alexander L Houck; Sahba Seddighi; Jane A Driver
Journal:  Curr Aging Sci       Date:  2018

4.  UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation.

Authors:  Lin Zhou; Yulong Shang; Zhi'an Jin; Wei Zhang; Chunlei Lv; Xiaodi Zhao; Yongqiang Liu; Naiyi Li; Jie Liang
Journal:  Cancer Biol Ther       Date:  2015-07-06       Impact factor: 4.742

5.  Prognostic significance of BRCA1 expression in gastric cancer.

Authors:  Wenjiao Chen; Jian Wang; Xiao Li; Jingying Li; Li Zhou; Tianzhu Qiu; Meiling Zhang; Ping Liu
Journal:  Med Oncol       Date:  2013-01-05       Impact factor: 3.064

6.  TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells.

Authors:  Annamaria Biroccio; Julien Cherfils-Vicini; Adeline Augereau; Sébastien Pinte; Serge Bauwens; Jing Ye; Thomas Simonet; Béatrice Horard; Karine Jamet; Ludovic Cervera; Aaron Mendez-Bermudez; Delphine Poncet; Renée Grataroli; Claire T'kint de Rodenbeeke; Erica Salvati; Angela Rizzo; Pasquale Zizza; Michelle Ricoul; Céline Cognet; Thomas Kuilman; Helene Duret; Florian Lépinasse; Jacqueline Marvel; Els Verhoeyen; François-Loïc Cosset; Daniel Peeper; Mark J Smyth; Arturo Londoño-Vallejo; Laure Sabatier; Vincent Picco; Gilles Pages; Jean-Yves Scoazec; Antonella Stoppacciaro; Carlo Leonetti; Eric Vivier; Eric Gilson
Journal:  Nat Cell Biol       Date:  2013-06-23       Impact factor: 28.824

Review 7.  Crosstalk between telomere maintenance and radiation effects: A key player in the process of radiation-induced carcinogenesis.

Authors:  Grace Shim; Michelle Ricoul; William M Hempel; Edouard I Azzam; Laure Sabatier
Journal:  Mutat Res Rev Mutat Res       Date:  2014-01-31       Impact factor: 5.657

Review 8.  Means to the ends: The role of telomeres and telomere processing machinery in metastasis.

Authors:  Nathaniel J Robinson; William P Schiemann
Journal:  Biochim Biophys Acta       Date:  2016-10-18

9.  Effects of TIN2 on telomeres and chromosomes in the human gastric epithelial cell line GES-1.

Authors:  Fan Fu; Hua Hu; Shuai Yang; Xiaoqiu Liang
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

10.  Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.

Authors:  Masahiro Kato; Masahiro Nakayama; Minako Agata; Kenichi Yoshida
Journal:  Tumour Biol       Date:  2012-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.